June 19, 2014
PACE Case: Controlling Pain 

   

A newly enrolled PACE participant came onto service with Stage 4 metastatic breast cancer, which had metastasized to the liver, bone, lungs, and lymph nodes. Upon enrollment, she had extensive pain, for which she was taking Dilaudid 2mg every 6 hours, and nausea (possibly narcotic related).  

 

Click here for the CareKinesis Clinical Pharmacist intervention. 

OMS Reporting 
 
CareKinesis has released the new 'OMS - Opioids' report for clients!  This report shows opioid PDE/billing information for participants through the end of the previous billing month. Direct access to this dispense history can be helpful when monitoring participant utilization because the CMS Overutilization Monitoring System (OMS) flags any records which include criteria met of >3 prescribers, >3 pharmacies, and daily morphine equivalent dosing >120mg for at least 90 consecutive days.

CareKinesis is happy to assist with any additional review and with morphine equivalent dosing calculations. If you are a client and do not yet have access to ReportPortal, please email info@carekinesis.com.  
Quote of the Month
 "We continue to be pleased with the services you provide and have seen
significant improvement in our drug costs over the past year.
We look forward to our ongoing relationship with you and CareKinesis."
 - Necie Borroni, Executive Director/CFO
   Mercy Medical, Daphne, AL
MU-2
 

EireneRx™ has achieved ONC HIT 2014 Edition Modular EHR certification. This certification designates that the software is capable of supporting eligible providers with meeting the Stage 1 and Stage 2 meaningful use measures required to qualify for funding under the American Recovery and Reinvestment Act (ARRA).  EireneRx™ version 2.0 meets the following certification criteria: 

  • ePrescribing, criteria 170.314(b)(3)
  • Medication List, criteria 170.314(a)(6)
  • Medication Allergy List, criteria 170.314(a)(7)
  • Drug-Drug and Drug-Allergy Interaction Checks, criteria 170.314(a)(2)
  • Drug Formulary Checks, criteria 170.314(a)(10)
  • Automated Numerator Capture, criteria 170.314(g)(1)
  • Authentication, Access Control and Authorization, criteria 170.314(d)(1)
  • Integrity, criteria 170.314(d)(8)
  • Automatic Log-off, criteria 170.314(d)(5)
  • Emergency Access, criteria 170.314(d)(6)
  • Safety-Enhanced Design, criteria 170.314(g)(3)
  • Quality Management System, criteria 170.314(g)(4) 

 

NPA - October 2014

 

This year, the National PACE Association's Annual Conference is in San Diego. More information is on the NPA website, here. Planning to attend? So are we. CareKinesis will be hosting a PACE appreciation dinner on Sunday, Oct. 26.  

 

Please save the date! More information will follow. 

 

CareKinesis Executives Honored 
 
Chairman and CEO, Dr. Calvin H. Knowlton, was named a Voltage Award winner by SmartCEO for his work in pharmacogenomics and medication risk management. Click here for the full release. CFO and VP of Finance, Brian W. Adams, was honored at the New Jersey Technology Council 2014 CFO of the Year Awards event for outstanding contributions to CareKinesis performance and accomplishments. Click here for additional information.
We are passionate about improving lives for PACE participants through medication risk mitigation. For more information, visit www.CareKinesis.com or call 888-974-2763.
  
Happy Summer!